Skip to main content
Big Ideas 2024 Is Here! Download Now
Subscribe
Subscribe

Genomic Revolution

Aims to provide exposure to DNA sequencing technology, gene editing, CRISPR, therapeutics, agricultural biology, and molecular diagnostics. These innovations can help in restructuring health care, agriculture, pharmaceuticals, and enhancing the quality of life.

genomic revolution, healthcare strategy, invest in dna sequencing

Investment Focus

DNA Sequencing

DNA Sequencing

Gene Editing

Gene Editing

Gene Therapy

Gene Therapy

Ag Bio

Ag Bio

Targeted Therapeutics

Targeted Therapeutics

Molecular Diagnostics

Molecular Diagnostics

Overview

  • Type: Active Equity
  • Typical # of Holdings: 30-50
  • Inception: Oct. 2014
  • Portfolio Manager: Catherine Wood
  • Analysts: Alexandra Urman
    Pierce Jamieson
    Rong Guo

Strategy Description

This actively managed equity strategy seeks long-term capital growth by investing in the US listed securities, including ADRs, of companies focused on the genomics revolution. Companies within this strategy aim to capture the substantial benefits of new products and services associated with technological and scientific developments in DNA sequencing, gene editing, targeted therapeutics, bioinformatics, and agricultural biology.

Availability

Strategy
ETF
Managed Account
Mutual Fund
ARK Genomic Revolution


In Japan

The content presented does not constitute investment advice, should not be used as the basis for any investment decision, and does not purport to provide any legal, tax or accounting advice. Certain of the statements contained on this website may be statements of future expectations and other forward-looking statements that are based on ARK’s current views and assumptions, and involve known and unknown risks and uncertainties that could cause actual results, performance or events to differ materially from those expressed or implied in such statements. Please remember that there are inherent risks involved with investing in the markets, and your investments may be worth more or less than your initial investment upon redemption. There is no guarantee that ARK’s objectives will be achieved. Further, there is no assurance that any strategies, methods, sectors, or any investment programs herein were or will prove to be profitable, or that any investment recommendations or decisions we make in the future will be profitable for any investor or client. Professional money management is not suitable for all investors. For full disclosures, please go to our Terms & Conditions page.

Strategy Characteristics

01

Actively managed, high conviction portfolio

02

Exposure to the intersection of health care and technology

03

Benchmark agnostic with low overlap to broad market indicies

04

Research process driven by ARK’s Open Research Ecosystem

Investment Team

You are leaving ark-invest.com
By clicking below you acknowledge that you are navigating away from ark-invest.com and will be connected to ark-funds.com ARK Investment Management LLC manages both web domains. Please take note of ARK’s privacy policy, terms of use, and disclosures that may vary between sites.